Latest filings (excl ownership)
6-K
Current report (foreign)
26 Sep 22
6-K
Current report (foreign)
29 Jun 22
20-F
2021 FY
Annual report (foreign)
28 Jun 22
6-K
Updated notice to holders of ADSs regarding termination of Deposit Agreement
21 Jun 22
6-K
Current report (foreign)
8 Jun 22
6-K
Current report (foreign)
31 May 22
6-K
Current report (foreign)
23 May 22
6-K
Current report (foreign)
18 May 22
6-K
Updated Financial Calendar for 2022
16 May 22
6-K
Current report (foreign)
16 May 22
NT 20-F/A
Notice of late annual filing (foreign) (amended)
16 May 22
NT 20-F
Notice of late annual filing (foreign)
2 May 22
6-K
Orphazyme announces update on in-court restructuring proceedings
29 Apr 22
6-K
Current report (foreign)
29 Apr 22
6-K
Current report (foreign)
7 Apr 22
6-K
Current report (foreign)
6 Apr 22
6-K
Current report (foreign)
6 Apr 22
6-K
Current report (foreign)
4 Apr 22
6-K
Current report (foreign)
31 Mar 22
15-12B
Securities registration termination
31 Mar 22
6-K
Current report (foreign)
31 Mar 22
6-K
Current report (foreign)
29 Mar 22
EFFECT
Notice of effectiveness
24 Mar 22
6-K
Orphazyme announces withdrawal of European Marketing Authorisation Application for arimoclomol for the treatment of Niemann-Pick disease type C
22 Mar 22
6-K
Current report (foreign)
21 Mar 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 22
POS AM
Prospectus update (post-effective amendment)
21 Mar 22
25
Voluntary exchange delisting
21 Mar 22
6-K
Current report (foreign)
18 Mar 22
6-K
Current report (foreign)
10 Mar 22
6-K
Current report (foreign)
3 Mar 22
6-K
Current report (foreign)
28 Feb 22
6-K
Orphazyme A/S Company announcement
24 Feb 22
6-K
Capital increase of 360,000 shares in Orphazyme A/S as a result of the utilization of the U.S. At-the-Market Offering Program
18 Feb 22
6-K
Current report (foreign)
15 Feb 22
6-K
Current report (foreign)
14 Feb 22
6-K
Current report (foreign)
11 Feb 22
6-K
Current report (foreign)
31 Jan 22
6-K
Current report (foreign)
25 Jan 22